Free tool
Oncology stocks
We cover 229 companies grouped under the Oncology theme. The median market value in the group is $73.69M. Across the group, the median move over the past trading day is 0.00%. 43% of the 224 with a 200-day average trade above it. Price change over the past year runs from −79.2% to +126.7% across the middle 80 percent of the group, with a median of −15.8%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
229 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| AAPG | Ascentage Pharma Group Internat | $1.58B | Small cap | −59.18% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% |
| PHIL.MI | Philogen S.p.A. | $1.11B | Small cap | +4.75% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +791.12% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| 4588.T | Oncolys BioPharma Inc. | $753.78M | Small cap | +539.50% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| CBIO | Crescent Biopharma, Inc. | $669.39M | Small cap | +26.46% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $628.73M | Small cap | −25.63% |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | $498.50M | Small cap | −90.91% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | $492.64M | Small cap | +1198.08% |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| AVCT.L | Avacta Group Plc | $440.62M | Small cap | +26.36% |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% |
| GALT | Galectin Therapeutics Inc. | $418.53M | Small cap | +4.27% |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% |
| FHTX | Foghorn Therapeutics Inc. | $397.29M | Small cap | +23.66% |
| AGEN | Agenus Inc. | $371.33M | Small cap | +81.72% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $368.27M | Small cap | +113.74% |
| CATX | Perspective Therapeutics, Inc. | $360.72M | Small cap | −12.47% |
| STRO | Sutro Biopharma, Inc. | $355.50M | Small cap | +138.11% |
| IMRX | Immuneering Corporation | $333.19M | Small cap | −0.77% |
| RAC.AX | Racura Oncology Ltd | $312.81M | Small cap | +87.39% |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% |
| PYXS | Pyxis Oncology, Inc. | $278.58M | Small cap | +145.59% |
| WHWK | Whitehawk Therapeutics, Inc. | $275.92M | Small cap | +167.40% |
| ALXO | ALX Oncology Holdings Inc. | $273.79M | Small cap | +65.00% |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +93.20% |
| GLSI | Greenwich LifeSciences, Inc. | $267.58M | Small cap | +56.21% |
| TNG.PA | Transgene SA | $263.11M | Small cap | −22.50% |
| ADAG | Adagene Inc. | $258.50M | Small cap | +75.80% |
| MGNX | MacroGenics, Inc. Common Stock | $257.35M | Small cap | +134.88% |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% |
| SPL.AX | Starpharma Holdings Limited | $248.56M | Small cap | +437.04% |
| IDD.DE | Innate Pharma S.A. | $243.27M | Small cap | −2.52% |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% |
| TARA | Protara Therapeutics, Inc. | $231.06M | Small cap | +21.05% |
| CHRS | Coherus Oncology, Inc. | $224.03M | Small cap | +27.19% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.56M | Small cap | +7.93% |
| NBP | NovaBridge Biosciences | $216.26M | Small cap | −58.44% |
| CUE | Cue Biopharma, Inc. | $209.58M | Small cap | +16.42% |
| MOLN | Molecular Partners AG | $170.46M | Small cap | +18.67% |
| MENS | Jyong Biotech Ltd. | $170.30M | Small cap | −95.62% |
| KZIA | Kazia Therapeutics Limited | $166.83M | Small cap | +86.94% |
| BINV.ST | BioInvent International AB (publ) | $162.35M | Small cap | −23.46% |
| OKUR | OnKure Therapeutics, Inc. | $155.52M | Small cap | +35.71% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| INDP | Indaptus Therapeutics, Inc. | $145.90M | Small cap | −82.19% |
| SCLP.L | Scancell Holdings plc | $136.80M | Small cap | −7.62% |
| HURA | TuHURA Biosciences, Inc. | $135.74M | Small cap | −26.55% |
| HPHA.DE | Heidelberg Pharma AG | $135.27M | Small cap | −31.15% |
| ADCT | ADC Therapeutics SA | $134.05M | Small cap | −67.39% |
| BDTX | Black Diamond Therapeutics, Inc. | $130.42M | Small cap | −20.91% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | $124.97M | Small cap | +80.49% |
| GNLX | Genelux Corporation | $123.52M | Small cap | −25.00% |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −29.30% |
| RVU.WA | Ryvu Therapeutics S.A. | $115.61M | Small cap | −36.99% |
| 4889.T | Renascience Inc. | $112.48M | Small cap | −40.80% |
| FARN.L | Faron Pharmaceuticals Oy | $110.28M | Small cap | −79.24% |
| ONCY | Oncolytics Biotech Inc. | $109.10M | Small cap | −19.28% |
| HBP.TO | Helix BioPharma Corp. | $106.76M | Small cap | +46.97% |
| 4575.T | CanBas Co., Ltd. | $103.86M | Small cap | −30.98% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| 4579.T | RaQualia Pharma Inc. | $93.23M | Micro cap | +3.46% |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% |
| MAIA | MAIA Biotechnology, Inc. | $84.56M | Micro cap | −15.76% |
| VRCA | Verrica Pharmaceuticals Inc. | $84.35M | Micro cap | −13.25% |
| CTOR | Citius Oncology, Inc. | $83.24M | Micro cap | −62.34% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| 4888.T | Stella Pharma Corporation | $80.24M | Micro cap | −11.75% |
| ELTX | Elicio Therapeutics, Inc. | $78.32M | Micro cap | −71.29% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| CRDF | Cardiff Oncology, Inc. | $76.56M | Micro cap | −54.65% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −33.62% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| MAAT.PA | MaaT Pharma SA | $65.60M | Micro cap | −33.91% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| HRTX | Heron Therapeutics, Inc. | $59.27M | Micro cap | −77.04% |
| 4564.T | OncoTherapy Science, Inc. | $56.36M | Micro cap | −25.00% |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% |
| ATX.AX | Amplia Therapeutics Limited | $54.23M | Micro cap | −14.71% |
| IMM.AX | Immutep Limited | $54.01M | Micro cap | −79.18% |
| 4572.T | Carna Biosciences, Inc. | $53.63M | Micro cap | +81.90% |
| TIL | Instil Bio, Inc. | $53.10M | Micro cap | −72.04% |
| 4597.T | Solasia Pharma K.K. | $51.40M | Micro cap | −18.92% |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% |
| PTX.AX | Prescient Therapeutics Limited | $50.63M | Micro cap | +63.41% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −24.12% |
| COIL.L | Coiled Therapeutics plc | $49.30M | Micro cap | −26.92% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| SVE.WA | Synthaverse S.A. | $47.18M | Micro cap | −36.25% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | $46.19M | Micro cap | −39.08% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.76% |
| MOC.WA | Molecure S.A. | $41.03M | Micro cap | −22.39% |
| CNTX | Context Therapeutics Inc. | $40.00M | Micro cap | −50.73% |
| 206A.T | PRISM BioLab Co.,LTD | $39.48M | Micro cap | −5.56% |
| SNT.AX | Syntara Limited | $38.09M | Micro cap | +1.89% |
| BCT.TO | BriaCell Therapeutics Corp. | $35.23M | Micro cap | −46.48% |
| BCTX | BriaCell Therapeutics Corp. | $35.06M | Micro cap | −46.97% |
| 190A.T | CHORDIA THERAPEUTICS INC | $33.98M | Micro cap | −59.32% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| ATNM | Actinium Pharmaceuticals, Inc. | $31.69M | Micro cap | −42.61% |
| MDNA.TO | Medicenna Therapeutics Corp. | $31.26M | Micro cap | −56.48% |
| 4582.T | SymBio Pharmaceuticals Limited | $31.19M | Micro cap | −57.43% |
| BYSI | BeyondSpring Inc. | $28.37M | Micro cap | −62.09% |
| CVM | CEL-SCI Corporation | $28.32M | Micro cap | −87.65% |
| NNG.WA | NanoGroup S.A. | $28.00M | Micro cap | −17.36% |
| LTRN | Lantern Pharma Inc. | $27.87M | Micro cap | −46.17% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +11.37% |
| EVAX | Evaxion A/S | $27.02M | Micro cap | +6.93% |
| PSTV | Plus Therapeutics Inc | $26.64M | Micro cap | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $26.45M | Micro cap | −76.75% |
| IMU.AX | Imugene Limited | $25.70M | Micro cap | −75.00% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| CLRB | Cellectar Biosciences, Inc. | $24.01M | Micro cap | −47.30% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $21.32M | Micro cap | −15.72% |
| DEX.ST | Dextech Medical AB | $20.09M | Micro cap | +26.38% |
| NOX.AX | Noxopharm Limited | $19.87M | Micro cap | −10.00% |
| ABVC | ABVC BioPharma, Inc. | $18.95M | Micro cap | −76.14% |
| RADX | Radiopharm Theranostics Limited | $18.29M | Micro cap | −58.87% |
| ALTME.PA | TME Pharma N.V. | $17.97M | Micro cap | +25.97% |
| TPST | Tempest Therapeutics, Inc. | $17.86M | Micro cap | −89.96% |
| AKTX | Akari Therapeutics, Plc | $17.72M | Micro cap | −72.42% |
| ABERA.ST | Abera Bioscience AB | $17.69M | Micro cap | +1.61% |
| B8FK.DE | Biofrontera AG | $17.36M | Micro cap | −3.07% |
| 4882.T | Perseus Proteomics Inc. | $17.25M | Micro cap | −56.56% |
| MDCX | Medicus Pharma Ltd. | $16.96M | Micro cap | −86.77% |
| RAD.AX | Radiopharm Theranostics Limited | $16.95M | Micro cap | −63.64% |
| CTXR | Citius Pharmaceuticals, Inc. | $16.57M | Micro cap | −57.88% |
| LSTA | Lisata Therapeutics, Inc. | $15.68M | Micro cap | −30.40% |
| INTS | Intensity Therapeutics, Inc. | $14.79M | Micro cap | −40.00% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| PHIO | Phio Pharmaceuticals Corp. | $13.94M | Micro cap | −40.89% |
| GTBP | GT Biopharma, Inc. | $13.52M | Micro cap | −74.55% |
| PDSB | PDS Biotechnology Corporation | $12.49M | Micro cap | −82.56% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| BLRX | BioLineRx Ltd. | $11.79M | Micro cap | −26.63% |
| MBRX | Moleculin Biotech, Inc. | $11.69M | Micro cap | −96.05% |
| TOVX | Theriva Biologics, Inc. | $11.16M | Micro cap | −42.10% |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −89.34% |
| 4598.T | Delta-Fly Pharma, Inc. | $9.28M | Micro cap | −81.75% |
| IMNN | Imunon, Inc. | $9.15M | Micro cap | −73.10% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −13.51% |
| AIM | AIM ImmunoTech Inc. | $7.61M | Micro cap | −89.69% |
| BOLT | Bolt Biotherapeutics, Inc. | $7.55M | Micro cap | −26.73% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| CANF | Can-Fite BioPharma Ltd. | $7.11M | Micro cap | −74.85% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | $7.05M | Micro cap | −19.44% |
| CHOSA.ST | Chosa Oncology AB | $7.01M | Micro cap | −9.00% |
| ITOC | iTonic Holdings Ltd. | $6.75M | Micro cap | −59.75% |
| NCNA | NuCana plc | $6.37M | Micro cap | −52.78% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
| PCSA | Processa Pharmaceuticals, Inc. | $5.95M | Micro cap | −60.00% |
| KAPA | Kairos Pharma, Ltd. | $5.88M | Micro cap | −77.97% |
| NFX.L | Nuformix plc | $5.85M | Micro cap | +80.68% |
| PER.AX | PERCHERON FPO [PER] | $5.45M | Micro cap | −54.55% |
| BCAB | BioAtla, Inc. | $5.20M | Micro cap | −86.04% |
| HCWB | HCW Biologics Inc. | $4.96M | Micro cap | −55.15% |
| APS.TO | Aptose Biosciences Inc | $4.41M | Micro cap | +50.00% |
| APVO | Aptevo Therapeutics Inc. | $4.34M | Micro cap | −92.52% |
| OSRH | OSR Health, Inc. | $4.09M | Micro cap | −80.93% |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −5.52% |
| RDHL | RedHill Biopharma Ltd. | $3.74M | Micro cap | −53.74% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $3.53M | Micro cap | +11.79% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.49M | Micro cap | −19.16% |
| GOVX | GeoVax Labs, Inc. | $3.34M | Micro cap | −96.67% |
| ARTL | Artelo Biosciences, Inc. | $3.27M | Micro cap | −97.37% |
| IVX.AX | Invion Limited | $2.83M | Micro cap | −72.31% |
| PPBT | Purple Biotech Ltd | $2.81M | Micro cap | −92.21% |
| VAL.L | ValiRx plc | $2.78M | Micro cap | −73.04% |
| RNAZ | TransCode Therapeutics, Inc. | $2.48M | Micro cap | −76.72% |
| PPCB | Propanc Biopharma, Inc. | $2.44M | Micro cap | −98.54% |
| NX1.AX | Nexalis Therapeutics Limited | $2.00M | Micro cap | −50.00% |
| SLXN | Silexion Therapeutics Corp | $1.97M | Micro cap | −95.11% |
| DCOY | Decoy Therapeutics Inc. | $1.95M | Micro cap | −95.78% |
| ATORX.ST | Alligator Bioscience AB (publ) | $1.88M | Micro cap | −99.27% |
| BDRX | Biodexa Pharmaceuticals Plc | $1.07M | Micro cap | −96.58% |
| PTP.DE | Pentixapharm Holding AG | $1.06M | Micro cap | +5.47% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.